Glutamic Acid

Glutamic Acid

SCHEMBL9280469

ClC1CC1.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM8 O00222 2/20 0.75
▸ GRM6 O15303 2/20 0.75
▸ GRM7 Q14831 2/20 0.75
▸ GRM4 Q14833 2/20 0.75
▸ GRIN2D O15399 1/20 0.75
▸ GRIN3B O60391 1/20 0.75
▸ GSR P00390 1/20 0.75
▸ CYP1A2 P05177 1/20 0.75
▸ GRIK1 P39086 1/20 0.75
▸ GRM5 P41594 1/20 0.75
▸ GRIA1 P42261 1/20 0.75
▸ GRIA2 P42262 1/20 0.75
▸ GRIA3 P42263 1/20 0.75
▸ SLC1A3 P43003 1/20 0.75
▸ SLC1A2 P43004 1/20 0.75
▸ SLC1A1 P43005 1/20 0.75
▸ GRIA4 P48058 1/20 0.75
▸ GRIN1 Q05586 1/20 0.75
▸ GRIN2A Q12879 1/20 0.75
▸ GRIK2 Q13002 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL5704264 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL1554237 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1330917 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1332144 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL2202 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL410241 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1330566 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1332007 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL43222 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1332297 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127974-B Markers for labeling biomolecules 上海宸安生物科技有限公司 2023-04-18 — — CN disclosed
CN-114127974-A Markers for labeling biomolecules 上海宸安生物科技有限公司 2022-03-01 — — CN disclosed
US-10030103-B2 Stable helical ionic polypeptides THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2018-07-24 — — US disclosed
EP-2646048-B1 STABLE HELICAL IONIC POLYPEPTIDES UNIV ILLINOIS (US) 2017-11-01 — — EP disclosed
US-20160215093-A1 STABLE HELICAL IONIC POLYPEPTIDES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-07-28 — — US disclosed
US-9243040-B2 Stable helical ionic polypeptides THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-01-26 — — US disclosed
US-20130274173-A1 STABLE HELICAL IONIC POLYPEPTIDES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-10-17 — — US disclosed
EP-2646048-A2 STABLE HELICAL IONIC POLYPEPTIDES The Board of Trustees of the University of Illinois (US) 2013-10-09 — — EP disclosed
WO-2012075147-A2 STABLE HELICAL IONIC POLYPEPTIDES BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-06-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10030103-B2 Stable helical ionic polypeptides GHITM, SLC7A1, PICALM GRM8 3859/4885GRM6 1569/4885GRM7 1577/4885
US-20130274173-A1 STABLE HELICAL IONIC POLYPEPTIDES GHITM, SLC7A1, PICALM GRM8 3859/4885GRM6 1569/4885GRM7 1577/4885
US-20160215093-A1 STABLE HELICAL IONIC POLYPEPTIDES GHITM, SLC7A1, PICALM GRM8 3859/4885GRM6 1569/4885GRM7 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback